Sector: Life Sciences

Latest content

Why the proposed covid TRIPs waiver is a solution in search of a problem

Rigorous correlation analysis makes the case that IP rights are not the barrier to vaccine and treatment access that advocates claim, argues David Torstensson

16 February 2022

Supreme People’s Court decision highlights Chinese pay-for-delay patent settlement pitfalls

Agreements ending patent invalidity challenges risk falling foul of the country’s Anti-Monopoly Law

14 February 2022

EU steps closer to unitary SPCs, but tricky questions remain unanswered

The European Commission has launched the next step of the process towards further harmonisation of the patent extension rights.

11 February 2022

Lack of mRNA tech transfer “a blessing in disguise” for WHO vaccine team, says Afrigen boss

Petro Terblanche tells IAM about the IP issues surrounding her team’s new replica of Moderna’s covid-19 vaccine

10 February 2022

How platform technologies are reshaping life sciences IP value creation

Versatile biotechnologies are changing patterns of collaboration among healthcare innovators

10 February 2022

Latest Enlarged Board of Appeal referral is a must-watch for US applicants

EPO Board of Appeal seeks clarification on joint applicants approach to priority rights

04 February 2022

GSK lands one of the biggest patent settlements of all time

The billion-dollar-plus agreement shows the astronomical financial value that individual pharmaceutical patents can have

03 February 2022

Flexibility of UK courts on full display in epic Neurim v Mylan dispute

Latest decision from London comes as plaintiff races against the clock to enforce soon-to-expire patent

01 February 2022

Big tech dominates brand value rankings led by $355 billion Apple portfolio

Tech sector brand assets gained significant value over the past year, according to the latest Brand Finance Global 500

31 January 2022

CRISPR IP deals continue apace despite legal battles

Spate of recent transactions show the value of gene-editing patents beyond Cas9

28 January 2022

Unlock unlimited access to all IAM content